Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PFE vs GSK✓SelectedUSD · GSKPFE vs GSK performance historyLatest closeAs of-0.10%11/16
Stock and ETF performance explorer

PFE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-23.8%
GSK return
+46.9%
Excess return
-70.7%
Maximum drawdown
-59.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-0.1%0.0%-0.1%
7D-1.3%-1.3%0.0%-0.7%
30D-1.0%+2.7%-3.7%-2.1%
3M+9.3%+2.7%+6.6%+7.9%
6M+17.6%+3.3%+14.3%+15.8%
YTD+23.7%+6.5%+17.2%+19.5%
1Y+22.9%+10.7%+12.2%+16.9%
3Y+17.7%+64.4%-46.7%-5.1%
5Y-23.8%+46.7%-70.4%-31.5%
All-23.8%+46.9%-70.7%-31.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling